Glucan-Based Macrophage Stimulators
- 1 May 1996
- journal article
- review article
- Published by Springer Nature in Clinical Immunotherapeutics
- Vol. 5 (5), 392-399
- https://doi.org/10.1007/bf03259335
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Randomized Phase I/II Trial of a Macrophage-Specific Immunomodulator (PGG-Glucan) in High-Risk Surgical PatientsAnnals of Surgery, 1994
- The Complex Pattern of Cytokines in Sepsis Association Between Prostaglandins, Cachectin, and InterleukinsAnnals of Surgery, 1991
- Isolation and characterization of beta-glucan receptors on human mononuclear phagocytes.The Journal of Experimental Medicine, 1991
- Dynamics of Blood Components and Peritoneal Fluid during Treatment of Murine E. coli Sepsis with β‐1, 3‐D‐Polyglucose DerivativesScandinavian Journal of Immunology, 1990
- Dynamics of Blood Components and Peritoneal Fluid during Treatment of Murine E. coli Sepsis with beta-1,3-D-polyglucose Derivatives.Scandinavian Journal of Immunology, 1990
- Macrophage Activation Decreases Macrophage Prostaglandin E2 Release in Experimental TraumaPublished by Wolters Kluwer Health ,1989
- Prostaglandin E2 (PGE2)-dependent Suppression of Interleukin α (IL-2) Production in Patients with Major TraumaPublished by Wolters Kluwer Health ,1987
- Enhancement of interleukin-1 and interleukin-2 production by soluble glucanInternational Journal of Immunopharmacology, 1987
- A comparative evaluation of particulate and soluble glucan in an endotoxin modelInternational Journal of Immunopharmacology, 1986
- Therapeutic Efficacy of Glucan in A Murine Model of Hepatic Metastatic DiseaseHepatology, 1985